Sisram Medical Ltd (HKG:1696)
2.140
+0.010 (0.47%)
Aug 21, 2026, 3:59 PM HKT
Sisram Medical Revenue
Sisram Medical had revenue of $171.42M USD in the half year ending June 30, 2026, with 1.60% growth. This brings the company's revenue in the last twelve months to $371.29M, up 7.35% year-over-year. In the year 2025, Sisram Medical had annual revenue of $365.35M with 4.65% growth.
Revenue (ttm)
$371.29M
Revenue Growth
+7.35%
P/S Ratio
0.34
Revenue / Employee
$354.63K
Employees
1,047
Market Cap
1.00B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 365.35M | 16.24M | 4.65% |
| Dec 31, 2024 | 349.11M | -10.18M | -2.83% |
| Dec 31, 2023 | 359.29M | 4.81M | 1.36% |
| Dec 31, 2022 | 354.48M | 60.19M | 20.45% |
| Dec 31, 2021 | 294.29M | 132.20M | 81.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Austar Lifesciences | 1.70B |
| Gaush Meditech | 1.54B |
| Vincent Medical Holdings | 932.78M |
| MicroTech Medical (Hangzhou) | 735.33M |
| Acotec Scientific Holdings | 717.35M |
| Shanghai HeartCare Medical Technology Corporation | 454.34M |
| MicroPort CardioFlow Medtech | 444.00M |
| Venus Medtech (Hangzhou) | 341.39M |
Sisram Medical News
- 1 day ago - Sisram Medical Earnings Call Transcript: H1 2026 - Transcripts
- 1 day ago - Sisram Medical Earnings release: H1 2026 - Filings
- 1 day ago - Sisram Medical Slides: H1 2026 - Filings
- 2 days ago - Sisram Medical Delivers Solid 2026 Interim Results - PRNewsWire
- 2 months ago - Sisram Medical Bolsters EBD and Injectables in Thailand to Unlock APAC Growth - PRNewsWire
- 3 months ago - Sisram Medical Investor Day Key Takeaways - PRNewsWire
- 5 months ago - Sisram Medical Earnings Call Transcript: H2 2025 - Transcripts
- 5 months ago - Sisram Medical Earnings release: H2 2025 - Filings